Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Amortization of Deferred Charges (2020 - 2025)

Historic Amortization of Deferred Charges for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $70000.0.

  • NeuroPace's Amortization of Deferred Charges changed N/A to $70000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $174000.0, marking a year-over-year decrease of 9162.66%. This contributed to the annual value of $1.4 million for FY2024, which is 4822.96% down from last year.
  • Latest data reveals that NeuroPace reported Amortization of Deferred Charges of $70000.0 as of Q3 2025.
  • In the past 5 years, NeuroPace's Amortization of Deferred Charges registered a high of $699000.0 during Q2 2024, and its lowest value of $49000.0 during Q1 2025.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $565000.0 (2022), whereas its average is $379235.3.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first crashed by 9793.15% in 2021, then surged by 101551.72% in 2022.
  • Quarter analysis of 5 years shows NeuroPace's Amortization of Deferred Charges stood at $67000.0 in 2021, then skyrocketed by 877.61% to $655000.0 in 2022, then grew by 5.19% to $689000.0 in 2023, then increased by 1.45% to $699000.0 in 2024, then plummeted by 89.99% to $70000.0 in 2025.
  • Its Amortization of Deferred Charges was $70000.0 in Q3 2025, compared to $55000.0 in Q2 2025 and $49000.0 in Q1 2025.